SterisCare has published its Annual Quality Review (AQR) for Financial Year 2025-26, presenting a comprehensive assessment of our manufacturing quality, deviation management, and continuous improvement initiatives over the past twelve months.
The report highlights a 12% improvement in batch rejection rates compared to FY 2024-25, zero critical deviations recorded across all production lines, and a 23% reduction in out-of-specification (OOS) investigations.
Key Metrics
- Batch rejection rate: 0.41% (vs. industry benchmark of 0.8%)
- OOS investigations: 12 (vs. 15 in FY24-25)
- Customer complaints per million units: 2.3
- CAPA closure rate within 30 days: 94%
The AQR is shared with all major institutional clients and regulatory authorities as part of our commitment to transparency. Full copies are available on request through our Quality Affairs department.
Keywords
